HRP20040366B1 - Novel bacterial poultry disease - Google Patents
Novel bacterial poultry diseaseInfo
- Publication number
- HRP20040366B1 HRP20040366B1 HRP20040366AA HRP20040366A HRP20040366B1 HR P20040366 B1 HRP20040366 B1 HR P20040366B1 HR P20040366A A HRP20040366A A HR P20040366AA HR P20040366 A HRP20040366 A HR P20040366A HR P20040366 B1 HRP20040366 B1 HR P20040366B1
- Authority
- HR
- Croatia
- Prior art keywords
- positive
- negative
- bacterium
- beta
- novel bacterial
- Prior art date
Links
- 208000027954 Poultry disease Diseases 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 abstract 1
- 102100026189 Beta-galactosidase Human genes 0.000 abstract 1
- 241000218561 Bibersteinia trehalosi Species 0.000 abstract 1
- 102100035882 Catalase Human genes 0.000 abstract 1
- 108010053835 Catalase Proteins 0.000 abstract 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- 241001293418 Mannheimia haemolytica Species 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 abstract 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 abstract 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 1
- 108010005774 beta-Galactosidase Proteins 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 abstract 1
- 229940093496 esculin Drugs 0.000 abstract 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- QHDUJTCUPWHNPK-UHFFFAOYSA-N methyl 7-methoxy-2h-indazole-3-carboxylate Chemical compound COC1=CC=CC2=C(C(=O)OC)NN=C21 QHDUJTCUPWHNPK-UHFFFAOYSA-N 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 210000004994 reproductive system Anatomy 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 abstract 1
- 229940120668 salicin Drugs 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10152307A DE10152307A1 (de) | 2001-10-26 | 2001-10-26 | Neue bakterielle Geflügelkrankheit |
| PCT/EP2002/011899 WO2003037367A2 (en) | 2001-10-26 | 2002-10-24 | New bacterium causing poultry disease and vaccine derived thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20040366A2 HRP20040366A2 (en) | 2005-04-30 |
| HRP20040366B1 true HRP20040366B1 (en) | 2012-05-31 |
Family
ID=7703460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20040366AA HRP20040366B1 (en) | 2001-10-26 | 2004-04-23 | Novel bacterial poultry disease |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US7794735B2 (xx) |
| EP (2) | EP1942181A1 (xx) |
| JP (2) | JP4447319B2 (xx) |
| KR (2) | KR101024887B1 (xx) |
| CN (1) | CN100471945C (xx) |
| AR (3) | AR037020A1 (xx) |
| AT (1) | ATE391767T1 (xx) |
| AU (1) | AU2002363173B2 (xx) |
| BR (1) | BR0213538A (xx) |
| CA (1) | CA2462652A1 (xx) |
| CO (1) | CO5580796A2 (xx) |
| CY (1) | CY1108178T1 (xx) |
| DE (2) | DE10152307A1 (xx) |
| DK (1) | DK1442114T3 (xx) |
| EC (1) | ECSP045083A (xx) |
| ES (1) | ES2304466T3 (xx) |
| HK (1) | HK1073862A1 (xx) |
| HR (1) | HRP20040366B1 (xx) |
| HU (1) | HU228692B1 (xx) |
| IL (1) | IL161223A0 (xx) |
| MA (1) | MA26293A1 (xx) |
| MX (1) | MXPA04003941A (xx) |
| MY (1) | MY138203A (xx) |
| NO (1) | NO333635B1 (xx) |
| NZ (1) | NZ532805A (xx) |
| PL (1) | PL206589B1 (xx) |
| PT (1) | PT1442114E (xx) |
| RU (4) | RU2430967C2 (xx) |
| SI (1) | SI1442114T1 (xx) |
| UA (2) | UA96948C2 (xx) |
| WO (1) | WO2003037367A2 (xx) |
| ZA (1) | ZA200402499B (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10152307A1 (de) * | 2001-10-26 | 2003-05-08 | Boehringer Ingelheim Vetmed | Neue bakterielle Geflügelkrankheit |
| KR20130027448A (ko) * | 2009-10-09 | 2013-03-15 | 코벤하븐스 유니버시테트 | 갈리박테리움 아나티스로부터의 세포용해 ｒｔｘ-독소 |
| CN102406936A (zh) * | 2011-11-22 | 2012-04-11 | 青岛易邦生物工程有限公司 | 一种鸡传染性鼻炎灭活疫苗佐剂 |
| CN102380092A (zh) * | 2011-11-22 | 2012-03-21 | 青岛易邦生物工程有限公司 | 一种鸡传染性鼻炎灭活疫苗 |
| EP2976102B1 (en) | 2013-03-18 | 2019-12-11 | Intervet International B.V. | Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica |
| RU2563885C1 (ru) * | 2014-06-03 | 2015-09-27 | Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) | Способ определения антител к бактериальным антигенам |
| CN104491856A (zh) * | 2014-12-07 | 2015-04-08 | 青岛易邦生物工程有限公司 | 一种禽肺病毒病灭活疫苗的生产方法 |
| CN108728558A (zh) * | 2018-05-31 | 2018-11-02 | 广西壮族自治区兽医研究所 | 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用 |
| CN111621450B (zh) * | 2020-07-10 | 2022-07-05 | 青岛易邦生物工程有限公司 | 一种鸭源鸡杆菌及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0865791A1 (fr) * | 1997-03-17 | 1998-09-23 | Vetoquinol S.A. | Utilisation d'une souche de Pasteurella haemolytica sérotype A6 pour la préparation d'un vaccin contre la pasteurellose bovine due à Pasteurella haemolytica |
| US5849305A (en) * | 1993-12-06 | 1998-12-15 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
| US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0625190B1 (en) * | 1992-10-14 | 1996-12-27 | Akzo Nobel N.V. | New bacterium causing poultry disease and vaccine derived thereof |
| RU94023126A (ru) * | 1994-06-16 | 1997-04-10 | Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко | Вакцина против пастереллеза свиней |
| RU2103355C1 (ru) * | 1995-11-23 | 1998-01-27 | Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии | Способ получения аттенуированных иммуногенных штаммов pasteurella multocida |
| WO2001044289A2 (en) * | 1999-12-17 | 2001-06-21 | University Of Guelph Office Of The Vice President Of Research | Modified leukotoxin gene and protein |
| US7521060B2 (en) | 2001-10-26 | 2009-04-21 | Boehringer Ingelheim Vetmedica S.A. De C.V. | Pathogen for bacterial poultry disease |
| DE10152307A1 (de) | 2001-10-26 | 2003-05-08 | Boehringer Ingelheim Vetmed | Neue bakterielle Geflügelkrankheit |
-
2001
- 2001-10-26 DE DE10152307A patent/DE10152307A1/de not_active Withdrawn
-
2002
- 2002-10-24 DK DK02802303T patent/DK1442114T3/da active
- 2002-10-24 UA UAA200900431A patent/UA96948C2/ru unknown
- 2002-10-24 IL IL16122302A patent/IL161223A0/xx unknown
- 2002-10-24 RU RU2007148219/15A patent/RU2430967C2/ru not_active IP Right Cessation
- 2002-10-24 BR BR0213538-8A patent/BR0213538A/pt active Pending
- 2002-10-24 JP JP2003539709A patent/JP4447319B2/ja not_active Expired - Fee Related
- 2002-10-24 EP EP08150505A patent/EP1942181A1/en not_active Withdrawn
- 2002-10-24 HU HU0402098A patent/HU228692B1/hu not_active IP Right Cessation
- 2002-10-24 KR KR1020097012926A patent/KR101024887B1/ko not_active IP Right Cessation
- 2002-10-24 CA CA002462652A patent/CA2462652A1/en not_active Abandoned
- 2002-10-24 PT PT02802303T patent/PT1442114E/pt unknown
- 2002-10-24 MX MXPA04003941A patent/MXPA04003941A/es active IP Right Grant
- 2002-10-24 AT AT02802303T patent/ATE391767T1/de active
- 2002-10-24 WO PCT/EP2002/011899 patent/WO2003037367A2/en active Application Filing
- 2002-10-24 EP EP02802303A patent/EP1442114B1/en not_active Expired - Lifetime
- 2002-10-24 KR KR1020047005166A patent/KR100954175B1/ko not_active IP Right Cessation
- 2002-10-24 NZ NZ532805A patent/NZ532805A/en not_active IP Right Cessation
- 2002-10-24 CN CNB028212517A patent/CN100471945C/zh not_active Expired - Fee Related
- 2002-10-24 SI SI200230699T patent/SI1442114T1/sl unknown
- 2002-10-24 RU RU2004116134/13A patent/RU2334792C2/ru not_active IP Right Cessation
- 2002-10-24 RU RU2007129099/15A patent/RU2456343C2/ru not_active IP Right Cessation
- 2002-10-24 ES ES02802303T patent/ES2304466T3/es not_active Expired - Lifetime
- 2002-10-24 MY MYPI20023986A patent/MY138203A/en unknown
- 2002-10-24 AU AU2002363173A patent/AU2002363173B2/en not_active Ceased
- 2002-10-24 UA UA20040503962A patent/UA89607C2/ru unknown
- 2002-10-24 DE DE60226057T patent/DE60226057T2/de not_active Expired - Lifetime
- 2002-10-24 PL PL369963A patent/PL206589B1/pl not_active IP Right Cessation
- 2002-10-25 AR ARP020104046A patent/AR037020A1/es active IP Right Grant
-
2004
- 2004-03-30 ZA ZA200402499A patent/ZA200402499B/en unknown
- 2004-04-22 CO CO04037170A patent/CO5580796A2/es active IP Right Grant
- 2004-04-23 NO NO20041675A patent/NO333635B1/no not_active IP Right Cessation
- 2004-04-23 EC EC2004005083A patent/ECSP045083A/es unknown
- 2004-04-23 HR HRP20040366AA patent/HRP20040366B1/xx not_active IP Right Cessation
- 2004-05-25 MA MA27700A patent/MA26293A1/fr unknown
-
2005
- 2005-07-26 HK HK05106369.5A patent/HK1073862A1/xx not_active IP Right Cessation
-
2008
- 2008-07-07 CY CY20081100706T patent/CY1108178T1/el unknown
- 2008-07-30 AR ARP080103284A patent/AR067732A2/es unknown
- 2008-09-10 RU RU2008136404/15A patent/RU2481393C2/ru not_active IP Right Cessation
-
2009
- 2009-02-25 US US12/392,594 patent/US7794735B2/en not_active Expired - Lifetime
- 2009-08-26 US US12/548,210 patent/US7964197B2/en not_active Expired - Fee Related
- 2009-09-02 AR ARP090103365A patent/AR073482A2/es not_active Application Discontinuation
- 2009-12-03 JP JP2009275445A patent/JP5087604B2/ja not_active Expired - Fee Related
-
2011
- 2011-05-09 US US13/103,987 patent/US20110212132A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
| US5849305A (en) * | 1993-12-06 | 1998-12-15 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
| EP0865791A1 (fr) * | 1997-03-17 | 1998-09-23 | Vetoquinol S.A. | Utilisation d'une souche de Pasteurella haemolytica sérotype A6 pour la préparation d'un vaccin contre la pasteurellose bovine due à Pasteurella haemolytica |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Upreti et al. | Isolation and characterization of a bacteriocin from a homofermentative Lactobacillus | |
| ATE299712T1 (de) | Stabilisatoren für lebendimpfstoffe | |
| HRP20040366B1 (en) | Novel bacterial poultry disease | |
| HUP0002475A2 (hu) | Módosított immunogén pneumolizinkészítmények mint vakcinák | |
| DE68908183T2 (de) | Thermophile alginat lyase aus bacillus stearothermophilus nrrlb-18394. | |
| DE69932425D1 (de) | Attenuierte salmonella mutanten, welche das vi-antigen konstant exprimieren | |
| Jonas et al. | Characterization of nine Pasteurella multocida isolates from avian cholera outbreaks in Indonesia | |
| Mutters et al. | Genus Pasteurella Trevisan 1887, 94, AL Nom. cons. Opin. 13, Jud. Comm. 1954 | |
| DK0465581T3 (da) | Erythromycinderivater | |
| IE780231L (en) | Oleandomycin derivatives | |
| FI864795A (fi) | Komposition innehaollande primicin. | |
| Xia et al. | Transportation of Helicobacter pylori cultures by optimal systems | |
| FI893932A0 (fi) | Expression av funktionella homologa och heterologa proteiner pao yttre membran av e.coli och andra gram-negativa bakterier. | |
| EP0165307A4 (en) | SYNTHESIS POLYPEPTIDE CORRESPONDING TO A PORTION OF THE THERMOLABILE ENTEROTOXIN FROM ESCHERICHIA COLI, COMPOSITIONS AND METHODS. | |
| DE3854416T2 (de) | Breitbandiger, sehr schneller Videoverstärker. | |
| ATE430800T1 (de) | Neuartige glykosyltransferase-gene | |
| DE3780080D1 (de) | Coccidiozide mittel. | |
| JPS548792A (en) | Novel preparation of ribostamycin | |
| Nador | Meat inspectional importance of abscesses observed in swine: III. Abscesses in the pelvic abattoir musculature. | |
| Hughes et al. | Gentamicin Resistance Plasmids in Hospital Infections. | |
| SE8301263D0 (sv) | Nya 3-azetidinyletyl-1-fenyl-2-imidazolidinonderivat och deras anvendning som neuroleptiska medel | |
| JPS57140726A (en) | Purification of physiologically active substance having carcinostatic action | |
| Megrelishvili et al. | Sporadic mesoscale variability of stratospheric aerosol | |
| Saito | On the Antibiotic Activity of the Eggs.(3) Influence of Inorganic Salts on the Antibiotic Activity of Egg White | |
| Potelov | The abundance and state of stock harp seals and hooded seals in the Greenland Sea. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20120926 Year of fee payment: 11 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20131024 |